Searched for
ESZOPICLONE TABLETS
Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Dr Reddy's, Sun Pharma recall drugs in US market: USFDADr Reddy's Laboratories and Sun Pharma are recalling products in the US due to manufacturing issues, as per the latest USFDA Enforcement Re...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 34%Given the way indices and broader markets have panned out, it is very likely that we are going to soon see the market hitting new highs. Th...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- A Healthy Dose! 4 midcap pharma stocks with upside potential of up to 36%After a long period of under performance, pharma stocks have seen interest coming back from institutional investors. This is because some t...
- Finally out of the woods? 4 midcap pharma stocks with an upside potential up to 34 %Pharma stocks had been underperforming for a very long time. Some time USFDA issues, at other instances of pricing pressure in US markets h...
- On a path to recovery: 5 midcap pharma stocks with an upside potential up to 32%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are mid-sized In...
- Midcaps with long term perspective; 9 stocks with high ROE & net profit marginMany investors, especially the ones sitting on cash are confused about what they should do with their existing stocks – buy the dip or not....
- Orchid Chemicals rallies over 8% on USFDA nod for Eszopiclone tabletsOrchid Chemicals Ltd rallied as much as 8.07 per cent in trade on Friday, after the pharma major received approval from the USFDA.
- Sensex rangebound, Nifty tests 7550; top ten stocks in focusThe Nifty index was trading near its crucial psychological level of 7550, weighed down by losses in capital goods, autos, FMCG and pharma s...
- Ten stocks in focus in Friday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nodThe company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone, a generic version of Lunesta, a sedative drug that is used for ...
- Lupin settles litigation over Lunesta tablets; stock upPharma major Lupin and its subsidiary Lupin Pharmaceuticals Inc have settled ongoing litigation with Sunovion Pharmaceuticals over Lunesta ...
- FDA nod for three Glenmark drugsGlenmark Pharmaceuticals said it has received the US health regulator's approval to market three generic products in the American market.
- Glenmark settles patent suit with Sepracor over insomnia drugGlenmark Pharmaceuticals today said it has entered into a settlement agreement with American firm Sepracor, which could pave way for the In...
Load More
